Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal uric acid reduction to improve vascular endothelial function in patients with chronic heart failure complicated by hyperuricemia.
Naganuma J, Sakuma M, Kitahara K, Kato T, Yokomachi J, Yamauchi F, Inoue R, Iida K, Kohno Y, Inoue K, Koshiji N, Abe S, Toyoda S, Inoue T; Excited UA study investigators. Naganuma J, et al. Among authors: kato t. Hypertens Res. 2023 Mar;46(3):688-696. doi: 10.1038/s41440-022-01116-7. Epub 2022 Dec 20. Hypertens Res. 2023. PMID: 36539463
The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
Sakuma M, Toyoda S, Arikawa T, Koyabu Y, Kato T, Adachi T, Suwa H, Narita JI, Anraku K, Ishimura K, Yamauchi F, Sato Y, Inoue T; For Excited UA study Investigators. Sakuma M, et al. Among authors: kato t. Clin Exp Nephrol. 2018 Dec;22(6):1379-1386. doi: 10.1007/s10157-018-1599-6. Epub 2018 Jun 18. Clin Exp Nephrol. 2018. PMID: 29916098
Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.
Sakuma M, Toyoda S, Arikawa T, Koyabu Y, Kato T, Adachi T, Suwa H, Narita JI, Anraku K, Ishimura K, Yamauchi F, Sato Y, Inoue T. Sakuma M, et al. Among authors: kato t. PLoS One. 2022 Jan 25;17(1):e0261445. doi: 10.1371/journal.pone.0261445. eCollection 2022. PLoS One. 2022. PMID: 35077456 Free PMC article. Clinical Trial.
Differential effect of a xanthine oxidase inhibitor on arterial stiffness and carotid atherosclerosis: a subanalysis of the PRIZE study.
Shiina K, Tomiyama H, Tanaka A, Yoshida H, Eguchi K, Kario K, Kato T, Teragawa H, Toyoda S, Ohishi M, Fukumoto Y, Takase B, Ishizu T, Node K; PRIZE Study Investigators. Shiina K, et al. Among authors: kato t. Hypertens Res. 2022 Apr;45(4):602-611. doi: 10.1038/s41440-022-00857-9. Epub 2022 Feb 15. Hypertens Res. 2022. PMID: 35169280 Clinical Trial.
12,401 results
You have reached the last available page of results. Please see the User Guide for more information.